Table 3.
Endpoints | Included studies | Participants | Effect model | Proportion (95%CI) | Begg test | Egger test | |
---|---|---|---|---|---|---|---|
PFS | 0.5 years | 13 | 623 | Random | 0.781 (0.688-0.862) | 0.3592 | 0.2175 |
1 year | 13 | 623 | Random | 0.387 (0.293-0.486) | 0.6688 | 0.5978 | |
1.5 years | 11 | 551 | Random | 0.117 (0.076-0.165) | 0.3487 | 0.3386 | |
2 years | 5 | 313 | Random | 0.069 (0.005-0.182) | 0.6242 | 0.4217 | |
OS | 0.5 years | 12 | 621 | Random | 0.943 (0.902-0.975) | 0.2857 | 0.1556 |
1 year | 12 | 621 | Random | 0.690 (0.585-0.786) | 0.3716 | 0.6814 | |
1.5 years | 12 | 621 | Random | 0.385 (0.246-0.533) | 0.4485 | 0.3606 | |
2 years | 9 | 480 | Random | 0.212 (0.117-0.324) | 0.4631 | 0.6764 | |
3 years | 5 | 246 | Fixed | 0.056 (0.028-0.091) | 0.8005 | 0.6243 |
OS, overall survival; PFS, progression-free survival; CI, confidence interval.